LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

CIDARA THERAPEUTICS INC

Closed

SectorHealthcare

217.69 104.98

Overview

Share price change

24h

Current

Min

217.51

Max

217.99

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-10.28% downside

News Sentiment

By Acuity

58%

42%

147 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

CIDARA THERAPEUTICS INC Chart

Past performance is not a reliable indicator of future results.

Related News

14 Nov 2025, 12:31 UTC

Acquisitions, Mergers, Takeovers

Merck to Buy Cidara Therapeutics in $9.2 Billion Deal -- Update

14 Nov 2025, 12:16 UTC

Acquisitions, Mergers, Takeovers

Merck to Buy Cidara Therapeutics in $9.2 Billion Deal

14 Nov 2025, 11:20 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Cidara Shares Nearly Double Premarket on Report of Takeover by Merck

14 Nov 2025, 11:11 UTC

Acquisitions, Mergers, Takeovers

Merck Nears $9.2 Billion Deal for Cidara, FT Reports, Citing Sources

23 Jun 2025, 12:05 UTC

Major Market Movers

Cidara Shares Soar Premarket After Positive Influenza Trial Results

14 Nov 2025, 16:30 UTC

Acquisitions, Mergers, Takeovers

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

14 Nov 2025, 13:19 UTC

Acquisitions, Mergers, Takeovers

This Biotech Stock Is Soaring 100%. Merck Is Buying It. -- Barrons.com

14 Nov 2025, 12:22 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pharma Sector Becoming Bidding Battlefield -- Market Talk

Peer Comparison

Price change

CIDARA THERAPEUTICS INC Forecast

Price Target

By TipRanks

-10.28% downside

12 Months Forecast

Average 195.33 USD  -10.28%

High 221.5 USD

Low 167 USD

Based on 8 Wall Street analysts offering 12 month price targets forCIDARA THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

4

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

18.88 / 19.67Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

147 / 374 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$

help-icon Live chat